Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 20 Neoplasms 19 Stomach Neoplasms 15 Colorectal Neoplasms 15 Lung Neoplasms 13 Endometrial Neoplasms 13 Pancreatic Neoplasms 11 Leukemia, Myeloid, Acute 10 Colonic Neoplasms 9 Carcinoma, Hepatocellular 9 Oropharyngeal Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Rectal Neoplasms 5 Mouth Neoplasms 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Head and Neck Neoplasms 5 Uterine Cervical Neoplasms 4 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × Observation × Clear all

NCT05775549 2024-09-20

FLAME

AstraZeneca

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡